A New Era in RSV Prevention

Topic(s):

Patient Conditions/Disease States , Clinical Outcomes , Patient-Reported Outcomes , Real World Evidence & Research , Clinical Outcomes , Comparative Effectiveness , Comparative Effectiveness Research , Patient-Reported Outcomes , Real World Evidence & Research

A webinar sponsored by Sanofi.

August 29, 2024 | 2-3PM ET
Free for AMCP members and non-members.

  1. Understand RSV Burden in US infants and review RSV epidemiology. 
  2. Review the pivotal nirsevimab clinical development studies establishing safety and efficacy and supporting ACIP recommendations. 
  3. Discuss global real-world data for nirsevimab efficacy, effectiveness and impact on RSV outcomes and nirsevimab safety. 
  4. Implementing Optimal Immunization Strategies to Help Reduce RSV LRTI

This webinar is only offered to payers, formulary committees, or other similar entities responsible for selecting drugs for coverage or reimbursement. To join this webinar, you must be registered as a user of FormularyDecisions®.

Register Now

Related

Title page of AMCP and FormularyDecision Webinar
Webinars

Breaking Down the Complexities of Product Evaluation in the Digital Era

An AMCP Webinar hosted by FormularyDecisions® The product review process is complex and can vary between organizations. Join us as our expert panel outlines best practices for conducting a comprehensive product review. Our panel represents the managed care organization and biopharma company viewpoints to discuss current challenges and opportunities to streamline the product review process; including ways to incorporate digital tools.
Managed Care Practice Issues

News & Resources by Topic

Visit the AMCP Calendar

AMCP offers a wide variety of educational opportunities, from events and webinars to online training.

News & Resources for:

Register Today
AMCP Nexus 2024 Logo Green

 

October 14-17 • • • MGM Grand, Las Vegas